Kuala Lumpur, Aug 12 — The World Health Organisation has announced that it will be carrying out tests on three new drugs for the treatment of COVID-19, which involves thousands of researchers at more than 600 hospitals across 52 countries.
According to the press release issued by WHO on Wednesday, the three new drugs are artesunate, a treatment for severe malaria; imatinib, a drug for certain types of cancer; and infliximab, a treatment for immune system disorders such as Crohn’s Disease.
An independent panel of experts selected these therapies for their potential in reducing the risk of death in hospitalized COVID-19 patients, and they were donated for the trial by their manufacturers, WHO said.
WHO director-general Tedros Adhanom Ghebreyesus stated that “finding more effective and accessible therapeutics for COVID-19 patients remains a critical need, and WHO is proud to lead this global effort”.
In its previous efforts, WHO has tested four drugs, namely remdesivir, hydroxychloroquine, lopinavir, and interferon, and the initial results showed that they had little or no effect on hospitalized patients with COVID-19.